Leveraging Regulatory Clarity in LDTs to Drive Laboratory Innovation
Jamie Platt, PhD
What steps should your lab take in response to shifting LDT oversight?
Jamie Platt, PhD
Dr. Jamie Platt is the CEO of Pictor, Inc., with over 20 years of leadership in genomics and molecular diagnostics. She has guided the development and commercialization of 40+ high-complexity tests, raised $25M in capital, and led two successful M&A exits totaling ~$1B. Platt holds multiple patents and sits on the boards of bioAffinity and DxTerity. She earned her PhD from Oregon State University and completed postdoctoral training at UC Berkeley.